BXM Wealth LLC Buys 52,515 Shares of Procter & Gamble Company (The) $PG

BXM Wealth LLC grew its stake in shares of Procter & Gamble Company (The) (NYSE:PG) by 851.4% in the fourth quarter, HoldingsChannel.com reports. The firm owned 58,683 shares of the company’s stock after buying an additional 52,515 shares during the quarter. BXM Wealth LLC’s holdings in Procter & Gamble were worth $8,410,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in the company. Czech National Bank increased its position in Procter & Gamble by 3.8% during the 3rd quarter. Czech National Bank now owns 594,914 shares of the company’s stock valued at $91,409,000 after purchasing an additional 21,825 shares during the period. Vega Investment Solutions lifted its position in shares of Procter & Gamble by 1.3% in the 2nd quarter. Vega Investment Solutions now owns 638,400 shares of the company’s stock worth $101,710,000 after purchasing an additional 8,500 shares during the period. Triodos Investment Management BV lifted its position in shares of Procter & Gamble by 7.3% in the 3rd quarter. Triodos Investment Management BV now owns 255,095 shares of the company’s stock worth $39,195,000 after purchasing an additional 17,400 shares during the period. Jump Financial LLC bought a new stake in shares of Procter & Gamble during the 2nd quarter valued at about $7,891,000. Finally, SVB Wealth LLC purchased a new position in shares of Procter & Gamble during the second quarter valued at about $12,725,000. 65.77% of the stock is owned by hedge funds and other institutional investors.

Procter & Gamble Stock Down 0.0%

PG stock opened at $143.06 on Monday. The stock has a market capitalization of $332.46 billion, a P/E ratio of 21.19, a P/E/G ratio of 5.04 and a beta of 0.41. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.72 and a quick ratio of 0.51. Procter & Gamble Company has a 1-year low of $137.62 and a 1-year high of $174.80. The business has a fifty day moving average price of $153.57 and a 200-day moving average price of $149.56.

Procter & Gamble (NYSE:PG) last issued its earnings results on Friday, January 23rd. The company reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.86 by $0.02. Procter & Gamble had a net margin of 19.30% and a return on equity of 32.21%. The company had revenue of $22.21 billion for the quarter, compared to analysts’ expectations of $22.36 billion. During the same quarter last year, the company posted $1.88 earnings per share. The firm’s quarterly revenue was up 1.5% on a year-over-year basis. Equities analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, February 17th. Shareholders of record on Friday, January 23rd were given a $1.0568 dividend. The ex-dividend date was Friday, January 23rd. This represents a $4.23 dividend on an annualized basis and a yield of 3.0%. Procter & Gamble’s dividend payout ratio is presently 62.67%.

Insider Transactions at Procter & Gamble

In other Procter & Gamble news, insider Balaji Purushothaman sold 12,827 shares of the firm’s stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $160.31, for a total transaction of $2,056,296.37. Following the sale, the insider directly owned 12,639 shares of the company’s stock, valued at $2,026,158.09. This trade represents a 50.37% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Moses Victor Javier Aguilar sold 15,169 shares of the stock in a transaction dated Friday, February 13th. The stock was sold at an average price of $162.28, for a total value of $2,461,625.32. Following the sale, the insider owned 44,735 shares of the company’s stock, valued at $7,259,595.80. This represents a 25.32% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 348,618 shares of company stock valued at $55,462,643. Company insiders own 0.20% of the company’s stock.

Wall Street Analyst Weigh In

PG has been the subject of several research reports. BNP Paribas Exane decreased their target price on Procter & Gamble from $172.00 to $164.00 and set an “outperform” rating for the company in a research report on Friday, January 16th. Wells Fargo & Company restated an “overweight” rating and set a $177.00 price target on shares of Procter & Gamble in a research report on Tuesday, February 17th. Barclays set a $155.00 price objective on Procter & Gamble in a report on Friday, January 16th. Rothschild & Co Redburn raised their price objective on Procter & Gamble from $155.00 to $157.00 and gave the company a “neutral” rating in a research report on Friday, January 23rd. Finally, JPMorgan Chase & Co. upgraded shares of Procter & Gamble from a “neutral” rating to an “overweight” rating and boosted their target price for the company from $157.00 to $165.00 in a report on Friday, January 23rd. Twelve equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $167.06.

Procter & Gamble Company Profile

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.